Fiber-Optic Ball Resonator Biosensor for Stable CD44 Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing cancer diagnostic methods, such as electrochemical and photoelectrochemical biosensors, face challenges with electrical interference, limited sensitivity, and specificity, particularly in vivo applications, necessitating a more reliable and sensitive detection method for breast cancer biomarkers like CD44.
Innovation Solution
A fiber-optic ball resonator biosensor is developed for dynamic in vitro detection, optimized for blood-mimicking conditions, using a syringe pump to simulate blood flow and integrated with a fiber-optic ball resonator to maintain accuracy under pressure changes, offering attomolar level detection and high selectivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If electrochemical and photoelectrochemical biosensors are used for high sensitivity detection, then detection sensitivity is improved, but electrical interference and device complexity increase
Solution Approach 1:
The patent replaces electrochemical transducers with an optical fiber-based resonator system. Instead of using electrical fields and chemical reactions that are susceptible to interference, the invention uses optical resonance phenomena where light interacts with the biosensor coating. This substitution eliminates electrical interference while maintaining high detection sensitivity through optical field-enhanced sensing mechanisms.
2Measurement precision
If ELISA kits are used for quantitative detection, then measurement precision is improved, but device complexity and sample preparation requirements increase
Solution Approach 1:
The patent extracts and eliminates the complex sample preparation and multiple reagent addition steps inherent in ELISA procedures. The optical fiber biosensor is designed to directly interact with the sample in a simplified format, removing unnecessary intermediate steps while preserving the ability to provide quantitative measurements through optical signal analysis.
Solution Approach 2:
The biosensor system performs self-detection and self-measurement functions. The optical fiber resonator automatically senses the presence and concentration of target analytes through changes in its resonance characteristics, eliminating the need for external complex processing equipment and multiple manual operations required by traditional ELISA methods.
3Adaptability or versatility
If biosensors are designed for in vivo applications, then adaptability is improved, but reliability decreases due to electrical interference
Solution Approach 1:
The patent replaces electrical sensing mechanisms with optical sensing that is inherently immune to electromagnetic interference from biological tissues and implanted devices. The optical fiber biosensor can be implanted or positioned in vivo without suffering from the electrical interference that plagues electrochemical sensors, thereby maintaining both adaptability for in vivo use and reliability of measurements.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biosensor achieves nearly instantaneous detection of low CD44 protein concentrations with high selectivity and sensitivity, demonstrating femtomolar detection limits and resistance to pressure changes, suitable for practical diagnostic applications.
Implementation Method 1
a fiber-optic ball resonator is developed for dynamic in vitro detection
Data Source
AI summary
Disclosed is a method for detecting breast cancer biomarkers, which can be applied in cancer diagnosis and monitoring the effectiveness of cancer therapy. This fiber-optic biosensor-based approach employs advanced photonic techniques to identify specific biomarkers with high sensitivity and specificity. The technical result is achieved through a system including a fabricated and biologically functionalized fiber-optic biosensor, immersed in a controlled fluidic environment that mimics in situ conditions. The biosensor is integrated into a commercially available catheter, which is placed within a flow-through tube containing serum. The work focuses on enhancing biosensor performance under simulated blood-like conditions, including optimization of sensor positioning, packaging modifications, and assessment of specificity and sensitivity under varying pressure levels. The aim is to improve the efficiency, accuracy, and reliability of cancer biomarker detection, ultimately enabling earlier and more precise diagnosis for patient benefit.


